Info
- Utilizzare la checkbox di selezione a fianco di ciascun documento per attivare le funzionalità di stampa, invio email, download nei formati disponibili del (i) record.
Animal cell culture [[electronic resource] ] : essential methods / / editor, John M. Davis
| Animal cell culture [[electronic resource] ] : essential methods / / editor, John M. Davis |
| Pubbl/distr/stampa | Hoboken, N.J., : John Wiley & Sons Inc., 2011 |
| Descrizione fisica | 1 online resource (380 p.) |
| Disciplina | 571.6/381 |
| Altri autori (Persone) | DavisJohn <1952-> |
| Collana | Essential Methods |
| Soggetto topico |
Cell culture - Technique
Tissue culture - Technique |
| ISBN |
1-283-23936-1
9786613239365 0-470-66982-9 0-470-66981-0 |
| Formato | Materiale a stampa  |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto |
CONTENTS; Contributors; Preface; Abbreviations; Protocols; 1 The Cell Culture Laboratory; 1.1 Introduction; 1.2 Methods and approaches; 1.3 Troubleshooting; Acknowledgements; References; 2 Sterilization; 2.1 Introduction; 2.2 Methods and approaches; 2.3 Troubleshooting; References; 3 Microscopy of Living Cells; 3.1 Introduction; 3.2 Methods and approaches; 3.3 Troubleshooting; Acknowledgements; References; 4 Basic Techniques and Media, the Maintenance of Cell Lines,and Safety; 4.1 Introduction; 4.2 Methods and approaches; 4.3 Troubleshooting; Acknowledgements; References
5 Development and Optimization of Serum- and Protein-freeCulture Media5.1 Introduction; 5.2 Methods and approaches; 5.3 Troubleshooting; 5.4 Conclusion; Acknowledgements; References; 6 Cryopreservation and Banking of Cell Lines; 6.1 Introduction; 6.2 Methods and approaches; 6.3 Troubleshooting; Acknowledgements; References; 7 Primary Culture of Specific Cell Types and the Establishmentof Cell Lines; 7.1 Introduction; 7.2 Methods and approaches; 7.3 Troubleshooting; References; 8 Cloning; 8.1 Introduction; 8.2 Methods and approaches; 8.3 Troubleshooting; References 9 The Quality Control of Animal Cell Lines and the Prevention,Detection and Cure of Contamination9.1 Introduction; 9.2 Methods and approaches; 9.3 Troubleshooting; References; 10 Systems for Cell Culture Scale-up; 10.1 Introduction; 10.2 Methods and approaches; 10.3 Troubleshooting; References; 11 Good Laboratory Practice in the Cell Culture Laboratory; 11.1 Introduction; 11.2 Background to GLP; 11.3 General GLP principles; 11.4 Study performance; 11.5 Good Manufacturing Practice; 11.6 Summary; References; Index |
| Record Nr. | UNINA-9910130871003321 |
| Hoboken, N.J., : John Wiley & Sons Inc., 2011 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Medicines from animal cell culture [[electronic resource] /] / [edited by] Glyn Stacey, John Davis
| Medicines from animal cell culture [[electronic resource] /] / [edited by] Glyn Stacey, John Davis |
| Pubbl/distr/stampa | Chichester ; ; Hoboken, N.J., : Wiley, c2007 |
| Descrizione fisica | 1 online resource (696 p.) |
| Disciplina |
571.638
615/.19 |
| Altri autori (Persone) |
StaceyG (Glyn)
DavisJohn <1952-> |
| Soggetto topico |
Animal cell biotechnology
Pharmaceutical biotechnology Stem cells - Transplantation Recombinant proteins - Therapeutic use |
| ISBN |
1-280-94135-9
9786610941353 0-470-72379-3 0-470-72378-5 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto |
Medicines from Animal Cell Culture; Contents; Contributors; Preface; List of Abbreviations; 1 The Development of Animal Cell Products: History and Overview 1; FUNDAMENTAL ELEMENTS OF CELL GROWTH MEDIA 15; 2 Water Purity and Regulations; 3 Development and Optimization of Serum-free and Protein-free Media; 4 Understanding Animal Sera: Considerations for Use in the Production of Biological Therapeutics; CELL ENGINEERING FOR RECOMBINANT PRODUCTS; 5 Expression of Recombinant Biomedical Products from Continuous Mammalian Cell Lines; 6 Production of Recombinant Viral Vaccine Antigens
7 A Brief Overview of the Baculovirus Expression System in Insect and Mammalian Cells8 Stability: Establishing Clones, Genetic Monitoring and Biological Performance; 9 Gene Transfer Vectors for Clinical Applications; TECHNOLOGY AND FACILITIES FOR CELL CULTURE SCALE-UP; 10 Systems for Cell Culture Scale-up; 11 Process Development and Design; 12 Facility Design for Cell Culture Biopharmaceuticals; 13 Monitoring, Control and Automation in Upstream Processing; 14 Services and Associated Equipment for Upstream Processing; 15 System and Process Validation PROCESSING AND PRESERVATION OF CELLS AND PRODUCTS16 Cell Harvesting; 17 Protein Concentration; 18 Purifi cation Methods; 19 Virus Safety of Cell-derived Biological Products; 20 Formulation and Freeze Drying for Lyophilized Biological Medicines; 21 Cell Preservation; PROPERTIES OF CELL PRODUCTS; 22 Product Characterization from Gene to Therapeutic Product; 23 Protein Analysis; 24 Glycosylation of Medicinal Products; 25 Immunogenicity of Impurities in Cell-Derived Vaccines; 26 Potency and Safety Assessment of Vaccines and Antitoxins:Use of Cell-based Assays 27 Product Stability and Accelerated Degradation StudiesCELLS AS PRODUCTS; 28 Cell Culture in Tissue Engineering; 29 The Use of Stem Cells in Cell Therapy; 30 Cells as Vaccines; RISK ASSESSMENT AND REGULATORY ASPECTS; 31 Risk Assessment of Cell Culture Procedures; 32 Standardization of Cell Culture Procedures; 33 Good Laboratory Practice for Cell Culture Processing; 34 Good Manufacturing Practice for Cell Culture Processing; 35 International Regulatory Framework; 36 New Areas: Cell Therapy and Tissue Engineering Products-Technical, Legal and Regulatory Considerations; Index |
| Record Nr. | UNINA-9910143745703321 |
| Chichester ; ; Hoboken, N.J., : Wiley, c2007 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Medicines from animal cell culture [[electronic resource] /] / [edited by] Glyn Stacey, John Davis
| Medicines from animal cell culture [[electronic resource] /] / [edited by] Glyn Stacey, John Davis |
| Pubbl/distr/stampa | Chichester ; ; Hoboken, N.J., : Wiley, c2007 |
| Descrizione fisica | 1 online resource (696 p.) |
| Disciplina |
571.638
615/.19 |
| Altri autori (Persone) |
StaceyG (Glyn)
DavisJohn <1952-> |
| Soggetto topico |
Animal cell biotechnology
Pharmaceutical biotechnology Stem cells - Transplantation Recombinant proteins - Therapeutic use |
| ISBN |
1-280-94135-9
9786610941353 0-470-72379-3 0-470-72378-5 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto |
Medicines from Animal Cell Culture; Contents; Contributors; Preface; List of Abbreviations; 1 The Development of Animal Cell Products: History and Overview 1; FUNDAMENTAL ELEMENTS OF CELL GROWTH MEDIA 15; 2 Water Purity and Regulations; 3 Development and Optimization of Serum-free and Protein-free Media; 4 Understanding Animal Sera: Considerations for Use in the Production of Biological Therapeutics; CELL ENGINEERING FOR RECOMBINANT PRODUCTS; 5 Expression of Recombinant Biomedical Products from Continuous Mammalian Cell Lines; 6 Production of Recombinant Viral Vaccine Antigens
7 A Brief Overview of the Baculovirus Expression System in Insect and Mammalian Cells8 Stability: Establishing Clones, Genetic Monitoring and Biological Performance; 9 Gene Transfer Vectors for Clinical Applications; TECHNOLOGY AND FACILITIES FOR CELL CULTURE SCALE-UP; 10 Systems for Cell Culture Scale-up; 11 Process Development and Design; 12 Facility Design for Cell Culture Biopharmaceuticals; 13 Monitoring, Control and Automation in Upstream Processing; 14 Services and Associated Equipment for Upstream Processing; 15 System and Process Validation PROCESSING AND PRESERVATION OF CELLS AND PRODUCTS16 Cell Harvesting; 17 Protein Concentration; 18 Purifi cation Methods; 19 Virus Safety of Cell-derived Biological Products; 20 Formulation and Freeze Drying for Lyophilized Biological Medicines; 21 Cell Preservation; PROPERTIES OF CELL PRODUCTS; 22 Product Characterization from Gene to Therapeutic Product; 23 Protein Analysis; 24 Glycosylation of Medicinal Products; 25 Immunogenicity of Impurities in Cell-Derived Vaccines; 26 Potency and Safety Assessment of Vaccines and Antitoxins:Use of Cell-based Assays 27 Product Stability and Accelerated Degradation StudiesCELLS AS PRODUCTS; 28 Cell Culture in Tissue Engineering; 29 The Use of Stem Cells in Cell Therapy; 30 Cells as Vaccines; RISK ASSESSMENT AND REGULATORY ASPECTS; 31 Risk Assessment of Cell Culture Procedures; 32 Standardization of Cell Culture Procedures; 33 Good Laboratory Practice for Cell Culture Processing; 34 Good Manufacturing Practice for Cell Culture Processing; 35 International Regulatory Framework; 36 New Areas: Cell Therapy and Tissue Engineering Products-Technical, Legal and Regulatory Considerations; Index |
| Record Nr. | UNINA-9910830522603321 |
| Chichester ; ; Hoboken, N.J., : Wiley, c2007 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Medicines from animal cell culture [[electronic resource] /] / [edited by] Glyn Stacey, John Davis
| Medicines from animal cell culture [[electronic resource] /] / [edited by] Glyn Stacey, John Davis |
| Pubbl/distr/stampa | Chichester ; ; Hoboken, N.J., : Wiley, c2007 |
| Descrizione fisica | 1 online resource (696 p.) |
| Disciplina |
571.638
615/.19 |
| Altri autori (Persone) |
StaceyG (Glyn)
DavisJohn <1952-> |
| Soggetto topico |
Animal cell biotechnology
Pharmaceutical biotechnology Stem cells - Transplantation Recombinant proteins - Therapeutic use |
| ISBN |
1-280-94135-9
9786610941353 0-470-72379-3 0-470-72378-5 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto |
Medicines from Animal Cell Culture; Contents; Contributors; Preface; List of Abbreviations; 1 The Development of Animal Cell Products: History and Overview 1; FUNDAMENTAL ELEMENTS OF CELL GROWTH MEDIA 15; 2 Water Purity and Regulations; 3 Development and Optimization of Serum-free and Protein-free Media; 4 Understanding Animal Sera: Considerations for Use in the Production of Biological Therapeutics; CELL ENGINEERING FOR RECOMBINANT PRODUCTS; 5 Expression of Recombinant Biomedical Products from Continuous Mammalian Cell Lines; 6 Production of Recombinant Viral Vaccine Antigens
7 A Brief Overview of the Baculovirus Expression System in Insect and Mammalian Cells8 Stability: Establishing Clones, Genetic Monitoring and Biological Performance; 9 Gene Transfer Vectors for Clinical Applications; TECHNOLOGY AND FACILITIES FOR CELL CULTURE SCALE-UP; 10 Systems for Cell Culture Scale-up; 11 Process Development and Design; 12 Facility Design for Cell Culture Biopharmaceuticals; 13 Monitoring, Control and Automation in Upstream Processing; 14 Services and Associated Equipment for Upstream Processing; 15 System and Process Validation PROCESSING AND PRESERVATION OF CELLS AND PRODUCTS16 Cell Harvesting; 17 Protein Concentration; 18 Purifi cation Methods; 19 Virus Safety of Cell-derived Biological Products; 20 Formulation and Freeze Drying for Lyophilized Biological Medicines; 21 Cell Preservation; PROPERTIES OF CELL PRODUCTS; 22 Product Characterization from Gene to Therapeutic Product; 23 Protein Analysis; 24 Glycosylation of Medicinal Products; 25 Immunogenicity of Impurities in Cell-Derived Vaccines; 26 Potency and Safety Assessment of Vaccines and Antitoxins:Use of Cell-based Assays 27 Product Stability and Accelerated Degradation StudiesCELLS AS PRODUCTS; 28 Cell Culture in Tissue Engineering; 29 The Use of Stem Cells in Cell Therapy; 30 Cells as Vaccines; RISK ASSESSMENT AND REGULATORY ASPECTS; 31 Risk Assessment of Cell Culture Procedures; 32 Standardization of Cell Culture Procedures; 33 Good Laboratory Practice for Cell Culture Processing; 34 Good Manufacturing Practice for Cell Culture Processing; 35 International Regulatory Framework; 36 New Areas: Cell Therapy and Tissue Engineering Products-Technical, Legal and Regulatory Considerations; Index |
| Record Nr. | UNINA-9910840832703321 |
| Chichester ; ; Hoboken, N.J., : Wiley, c2007 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||